Flexeder, C. ; Zock, J.P.* ; Jarvis, D.* ; Verlato, G.* ; Olivieri, M.* ; Benke, G.* ; Abramson, M.J.* ; Sigsgaard, T.* ; Svanes, C.* ; Torén, K.* ; Nowak, D.* ; Jõgi, R.* ; Martinez-Moratalla, J.* ; Demoly, P.* ; Janson, C.* ; Gislason, T.* ; Bono, R.* ; Holm, M.* ; Franklin, K.A.* ; Garcia-Aymerich, J.* ; Siroux, V.* ; Leynaert, B.* ; Dorado Arenas, S.* ; Corsico, A.G.* ; Pereira-Vega, A.* ; Probst-Hensch, N.* ; Urrutia Landa, I.* ; Schulz, H. ; Heinrich, J.
Second-hand smoke exposure in adulthood and lower respiratory health during 20 year follow up in the European Community Respiratory Health Survey.
Respir. Res. 20:33 (2019)
Early life exposure to tobacco smoke has been extensively studied but the role of second-hand smoke (SHS) for new-onset respiratory symptoms and lung function decline in adulthood has not been widely investigated in longitudinal studies. Our aim is to investigate the associations of exposure to SHS in adults with respiratory symptoms, respiratory conditions and lung function over 20 years.We used information from 3011 adults from 26 centres in 12 countries who participated in the European Community Respiratory Health Surveys I-III and were never or former smokers at all three surveys. Associations of SHS exposure with respiratory health (asthma symptom score, asthma, chronic bronchitis, COPD) were analysed using generalised linear mixed-effects models adjusted for confounding factors (including sex, age, smoking status, socioeconomic status and allergic sensitisation). Linear mixed-effects models with additional adjustment for height were used to assess the relationships between SHS exposure and lung function levels and decline.Reported exposure to SHS decreased in all 26 study centres over time. The prevalence of SHS exposure was 38.7% at baseline (1990-1994) and 7.1% after the 20-year follow-up (2008-2011). On average 2.4% of the study participants were not exposed at the first, but were exposed at the third examination. An increase in SHS exposure over time was associated with doctor-diagnosed asthma (odds ratio (OR): 2.7; 95% confidence interval (95%-CI): 1.2-5.9), chronic bronchitis (OR: 4.8; 95%-CI: 1.6-15.0), asthma symptom score (count ratio (CR): 1.9; 95%-CI: 1.2-2.9) and dyspnoea (OR: 2.7; 95%-CI: 1.1-6.7) compared to never exposed to SHS. Associations between increase in SHS exposure and incidence of COPD (OR: 2.0; 95%-CI: 0.6-6.0) or lung function (beta: - 49 ml; 95%-CI: -132, 35 for FEV1 and beta: - 62 ml; 95%-CI: -165, 40 for FVC) were not apparent.Exposure to second-hand smoke may lead to respiratory symptoms, but this is not accompanied by lung function changes.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Adults ; Smoking ; Lung Function ; Asthma ; Respiratory Symptoms ; Bronchitis ; Ecrhs; Environmental Tobacco-smoke; Passive Smoking; Lung-function; Parental Smoking; Pulmonary-function; Asthma; Disease; Risk; Population; Symptoms
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2019
Prepublished im Jahr
HGF-Berichtsjahr
2019
ISSN (print) / ISBN
1465-9921
e-ISSN
1465-993X
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 20,
Heft: 1,
Seiten: ,
Artikelnummer: 33
Supplement: ,
Reihe
Verlag
BioMed Central
Verlagsort
Campus, 4 Crinan St, London N1 9xw, England
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Epidemiology (EPI)
POF Topic(s)
30202 - Environmental Health
80000 - German Center for Lung Research
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-504000-009
G-504000-008
G-501800-401
Förderungen
Copyright
Erfassungsdatum
2019-03-15